Podcast: SCAI President Expects Long-Term Success For Absorb Scaffold
This article was originally published in The Gray Sheet
James Blankenship, the outgoing president of the Society for Cardiovascular Angiography and Interventions, spoke to The Gray Sheet following the positive panel recommendation for Abbott's fully bioabsorbable Absorb stent.
You may also be interested in...
While a panel of FDA experts almost unanimously voted to recommend Abbott's fully bioabsorbable Absorb scaffold, analysts say the stent is unlikely to take significant market share, at least in its current form.
Companion diagnostics are needed increasingly by pharma companies to justify the safety and effectiveness of their products. With specific first-time EU regulation of these products within sight – and urgently needed – is there a risk of delays to these products being able to demonstrate compliance?
Draft policy moots crowdfunding for high-cost rare diseases alongside financial support for those "amenable to one-time treatment" but falls way short of some patient groups' expectations.